Robotics Bottleneck Research机器人瓶颈研究

Main主页 / companies / public / rainbow-robotics

company

Rainbow RoboticsRainbow Robotics 277810

Country国家 Korea韩国

Systems系统 Muscle肌肉 · Integration集成

Bottlenecks瓶颈 P13 Dexterous manipulation灵巧操作 · P17 Integration, uptime, service集成、在线率与服务

Market cap市值 Live, via TradingView.实时数据,来自 TradingView。

Humanoid and collaborative robot platforms from the KAIST Hubo lineage, majority-owned by Samsung Electronics since 2025. H1 2026 revenue ~KRW 21.4bn, with Samsung itself supplying roughly 27% of it; still operating-loss-making against an ~KRW 8.8tn market cap.

源自 KAIST Hubo 团队的人形与协作机器人平台,自 2025 年起由三星电子控股。2026 年上半年收入约 214 亿韩元,其中三星自身贡献约 27%;公司仍处于营业亏损状态,市值约 8.8 万亿韩元。

What it doesHumanoid and collaborative robot platforms from the KAIST Hubo lineage, majority-owned by Samsung Electronics since 2025. H1 2026 revenue ~KRW 21.4bn, with Samsung itself supplying roughly 27% of it; still operating-loss-making against an ~KRW 8.8tn market cap.

在干什么源自 KAIST Hubo 团队的人形与协作机器人平台,自 2025 年起由三星电子控股。2026 年上半年收入约 214 亿韩元,其中三星自身贡献约 27%;公司仍处于营业亏损状态,市值约 8.8 万亿韩元。

Name sheetRainbow Robotics

Why it mattersKorea's humanoid pioneer, a KAIST Hubo-lineage spinout now majority-owned by Samsung Electronics, and the clearest Korean parallel to the Hyundai/Boston Dynamics structure: a chaebol assembling humanoid capability by taking control of an independent developer rather than sourcing merchant hardware. It is the Korean case study for this site's recurring related-party theme.

为何重要韩国人形机器人的先行者——源自 KAIST Hubo 团队的分拆公司,现由三星电子控股——是现代/波士顿动力结构在韩国最清晰的对照:财阀通过取得独立开发商的控制权来组装人形能力,而非在市场上采购硬件。这是本站反复出现的关联方主题在韩国的典型案例。

Caveat

For Q2 2026 (three months to June 2026), disclosed via DART and reported in Korean financial press on 2026-08-17, consolidated revenue was KRW 12.31bn, up 97.9% year over year, with an operating loss of KRW 2.03bn, an operating-loss margin of roughly 16.5%, improved from roughly 33.1% a year earlier as revenue grew faster than losses. On a reconciled H1 2026 basis (Q1 KRW 9.07bn + Q2 KRW 12.31bn), total revenue was approximately KRW 21.4bn, already matching the whole of FY2025 revenue in six months.

Mobile-humanoid revenue was KRW 8.65bn, 40.5% of that H1 total. Samsung Electronics, Rainbow's controlling shareholder at roughly 35% since March 2025, which consolidates Rainbow as a subsidiary, was itself the largest disclosed customer, contributing roughly KRW 5.68bn of H1 2026 revenue (about 27% of the total; KRW 2.41bn in Q1, KRW 3.27bn in Q2).

FY2025 consolidated revenue was KRW 21.1bn, up 76.4% year over year, with Samsung-related revenue of KRW 10.4bn, a 7.2x increase over 2024, already roughly half of full-year sales. This is not a merchant-supplier story: Rainbow's single largest disclosed customer is also its controlling parent, so revenue growth and controlling-shareholder demand cannot be cleanly separated in the disclosed figures, and no non-Samsung enterprise customer or humanoid unit-shipment count has been disclosed.

The market has priced a far larger outcome than the income statement shows: market capitalisation was approximately KRW 8.81tn as of 2026-08-24 against FY2025 revenue of only KRW 21.1bn (trailing P/S over 400x) and against an annualised H1 2026 run-rate of roughly KRW 43bn (P/S still above 200x), on a business that remains operating-loss-making. The 52-week range (KRW 265,500 to KRW 979,000) shows the stock has moved by a factor of nearly 4x within a year on narrative rather than on any disclosed profitability inflection.

风险提示

2026 年二季度(截至 2026 年 6 月的三个月),经 DART 披露并于 2026-08-17 由韩国财经媒体报道:合并收入 123.1 亿韩元,同比 +97.9%,营业亏损 20.3 亿韩元——营业亏损率约 16.5%,较上年同期约 33.1% 有所改善,因收入增速快于亏损增速。按可核对口径计算的 2026 年上半年(一季度 90.7 亿韩元 + 二季度 123.1 亿韩元),总收入约 214 亿韩元——半年内已达到 FY2025 全年收入水平。

移动人形机器人收入为 86.5 亿韩元,占上半年总收入的 40.5%。三星电子——自 2025 年 3 月起持股约 35% 的控股股东,将 Rainbow 并表为子公司——本身即是最大的已披露客户,贡献了上半年约 56.8 亿韩元收入(约占总收入的 27%;一季度 24.1 亿韩元,二季度 32.7 亿韩元)。

FY2025 合并收入 211 亿韩元,同比 +76.4%,其中三星相关收入 104 亿韩元——较 2024 年增长 7.2 倍——已占全年销售额的近一半。这不是一个市场化供应商的故事:Rainbow 已披露的最大客户同时也是其控股母公司,因此收入增长与控股股东需求在已披露数据中无法清晰区分,且未披露任何非三星的企业客户或人形机器人出货量。

市场定价的预期远超损益表所反映的现实:截至 2026-08-24,市值约 8.81 万亿韩元,对应 FY2025 收入仅 211 亿韩元(静态市销率超 400 倍),对应 2026 年上半年年化收入约 430 亿韩元(市销率仍超 200 倍)——而公司仍处于营业亏损状态。52 周股价区间(26.55 万至 97.9 万韩元)显示股价一年内波动近 4 倍,驱动力是叙事而非任何已披露的盈利拐点。

ProductHumanoid robot platforms, collaborative robot arms, and the in-house actuators inside them

Value accrualHumanoid and cobot platform sales, currently driven substantially by a controlling-shareholder customer (Samsung Electronics) rather than arm's-length demand

Key riskH1 2026 revenue ~KRW 21.4bn against a market cap of ~KRW 8.81tn (trailing P/S over 400x), still operating-loss-making, with the controlling shareholder (Samsung Electronics, ~35%) also its largest disclosed customer (~27% of H1 revenue), a related-party concentration that clouds any merchant-demand read of the growth.

Key risk2026 年上半年收入约 214 亿韩元,对应市值约 8.81 万亿韩元(静态市销率超 400 倍),公司仍处于营业亏损状态;控股股东三星电子(持股约 35%)同时是其最大已披露客户(占上半年收入约 27%)——这一关联方集中度使得增长中有多少属于市场化需求难以判断。

Bottlenecks瓶颈 P13 Dexterous manipulation灵巧操作 · P17 Integration, uptime, service集成、在线率与服务

Class
public
Country
KR
HQ
Daejeon, South Korea
Layer
Robot OEM / Humanoid & collaborative platforms
Systems
muscle · body
Caveat stance
avoid
Ticker
277810
Exchange
KOSDAQ
Valuation tier
3
Last verified
2026-08-26
Sources
S-PUB-032 · S-PUB-033
Translated fields
what_it_does_en · why_it_matters_en · caveat_en · key_risk_en
Chain position
midstream
COMPANY RESEARCH公司研究 Commercial evidence商业证据 Expand +展开 + Collapse −收起 −
Commercial evidence shows how far a company has moved from a product claim to repeatable customer value. We look for a defined customer task, paid deployment, operating results, the human help required, and economics that can support repeat use. Missing information stays unassessed; it does not count as evidence against the company.商业证据用于判断一家公司从产品宣称走到了可重复客户价值的哪一步。我们关注明确的客户任务、付费部署、运行结果、所需人工协助,以及能否支持重复采用的经济性。缺失信息保持未评估,不会被当作对公司的负面证据。 Each item below applies only to the cited document and period. It should be read with its evidence class, review date, and stated limits.以下每项内容仅适用于所引文件与期间,阅读时应同时考虑证据类别、核查日期与已说明的局限。
Customer and task
客户与任务
Not yet assessed in this structured record.本结构化记录尚未评估。
Deployment and payment
部署与付款
Not yet assessed in this structured record.本结构化记录尚未评估。
Task results and human assistance
任务结果与人工协助
Not yet assessed in this structured record.本结构化记录尚未评估。
Cost and repeat purchases
成本与复购
Not yet assessed in this structured record.本结构化记录尚未评估。
What the evidence cannot establish
证据的局限
Not yet assessed in this structured record.本结构化记录尚未评估。
How to evaluate commercial evidence如何评估商业证据